Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MabThera Drug Utilisation Study and Patient Alert Card Evaluation in Non-Oncology Patients in Europe: An Infusion Centre-Based Approach

NCT02654379 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02654379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MabThera Drug Utilisation Study and Patient Alert Card Evaluation in Non-Oncology Patients in Europe: An Infusion Centre-Based Approach
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
December 18, 2015
Completion date
September 29, 2017
Enrollment
1,408 (actual)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

off-label use